ESR1 and breast carcinoma: We examined the effect of lutein on a broader panel of human breast cancer cells, including BT-474 (ER/PR+HER2+), MDA-MB-453 (triple-negative), and MDA-MB-231 (triple-negative) cell lines, and found that all showed similar lutein-mediated growth inhibition profiles (Figure 1B).